Michael Schmelmer
- Business Wire
Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
Strong R&D commitment to developing therapeutics against SARS-CoV-2 virus Overall R&D investment up 7% to 3.7 billion EUR in 2020…
Read More » - Technology
Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
Ingelheim, Germany & Mountain View, Calif., United States: ● Quantum computing offers the potential to significantly accelerate and optimize the…
Read More »